IOL CHEMICALS & PHARM. | MARKSANS PHARMA. | IOL CHEMICALS & PHARM./ MARKSANS PHARMA. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 24.7 | 53.3% | View Chart |
P/BV | x | 1.5 | 4.5 | 33.1% | View Chart |
Dividend Yield | % | 1.0 | 0.3 | 362.8% |
IOL CHEMICALS & PHARM. MARKSANS PHARMA. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
MARKSANS PHARMA. Mar-23 |
IOL CHEMICALS & PHARM./ MARKSANS PHARMA. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 74 | 721.2% | |
Low | Rs | 272 | 39 | 703.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 40.9 | 924.0% | |
Earnings per share (Unadj.) | Rs | 23.7 | 5.9 | 404.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 7.0 | 450.9% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.50 | 800.0% | |
Avg Dividend yield | % | 1.0 | 0.9 | 111.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 38.5 | 666.8% | |
Shares outstanding (eoy) | m | 58.71 | 453.16 | 13.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.4 | 77.4% | |
Avg P/E ratio | x | 17.1 | 9.7 | 176.6% | |
P/CF ratio (eoy) | x | 12.8 | 8.1 | 158.6% | |
Price / Book Value ratio | x | 1.6 | 1.5 | 107.2% | |
Dividend payout | % | 16.9 | 8.5 | 197.6% | |
Avg Mkt Cap | Rs m | 23,743 | 25,631 | 92.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2,394 | 70.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 18,521 | 119.7% | |
Other income | Rs m | 256 | 593 | 43.2% | |
Total revenues | Rs m | 22,427 | 19,115 | 117.3% | |
Gross profit | Rs m | 2,257 | 3,393 | 66.5% | |
Depreciation | Rs m | 462 | 519 | 89.0% | |
Interest | Rs m | 165 | 91 | 180.4% | |
Profit before tax | Rs m | 1,887 | 3,377 | 55.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 723 | 68.4% | |
Profit after tax | Rs m | 1,391 | 2,653 | 52.4% | |
Gross profit margin | % | 10.2 | 18.3 | 55.6% | |
Effective tax rate | % | 26.2 | 21.4 | 122.5% | |
Net profit margin | % | 6.3 | 14.3 | 43.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 16,997 | 56.9% | |
Current liabilities | Rs m | 5,025 | 3,654 | 137.5% | |
Net working cap to sales | % | 20.9 | 72.0 | 29.1% | |
Current ratio | x | 1.9 | 4.7 | 41.3% | |
Inventory Days | Days | 43 | 6 | 758.8% | |
Debtors Days | Days | 8 | 82 | 10.1% | |
Net fixed assets | Rs m | 11,017 | 5,246 | 210.0% | |
Share capital | Rs m | 587 | 453 | 129.6% | |
"Free" reserves | Rs m | 14,490 | 16,998 | 85.2% | |
Net worth | Rs m | 15,077 | 17,452 | 86.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 22,242 | 93.0% | |
Interest coverage | x | 12.5 | 38.0 | 32.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.8 | 128.7% | |
Return on assets | % | 7.5 | 12.3 | 61.0% | |
Return on equity | % | 9.2 | 15.2 | 60.7% | |
Return on capital | % | 13.6 | 19.9 | 68.5% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 7.3 | 0.0% | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | 1,348 | 0.0% | |
Fx inflow | Rs m | 5,930 | 6,491 | 91.4% | |
Fx outflow | Rs m | 6,052 | 1,348 | 448.8% | |
Net fx | Rs m | -122 | 5,143 | -2.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 2,374 | 51.5% | |
From Investments | Rs m | -1,200 | -2,592 | 46.3% | |
From Financial Activity | Rs m | -41 | 1,978 | -2.1% | |
Net Cashflow | Rs m | -18 | 1,760 | -1.0% |
Indian Promoters | % | 48.2 | 43.9 | 109.9% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 20.7 | 8.2% | |
FIIs | % | 1.4 | 15.6 | 9.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 56.2 | 92.3% | |
Shareholders | 130,003 | 254,699 | 51.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | MARKSANS PHARMA. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | 2.23% | -0.44% |
1-Month | -4.51% | 23.38% | 2.15% |
1-Year | -4.09% | 125.64% | 49.82% |
3-Year CAGR | -12.01% | 48.37% | 14.21% |
5-Year CAGR | 15.35% | 48.44% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the MARKSANS PHARMA. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of MARKSANS PHARMA. the stake stands at 43.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of MARKSANS PHARMA..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
MARKSANS PHARMA. paid Rs 0.5, and its dividend payout ratio stood at 8.5%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of MARKSANS PHARMA..
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.